These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34947984)

  • 21. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
    Lim WLF; Huynh K; Chatterjee P; Martins I; Jayawardana KS; Giles C; Mellett NA; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Drew BG; Masters CL; Meikle PJ; Martins RN;
    J Alzheimers Dis; 2020; 76(1):303-315. PubMed ID: 32474467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Gómez-Ariza JL
    J Pharm Biomed Anal; 2015 Mar; 107():75-81. PubMed ID: 25575172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
    Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
    J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
    Wang G; Zhou Y; Huang FJ; Tang HD; Xu XH; Liu JJ; Wang Y; Deng YL; Ren RJ; Xu W; Ma JF; Zhang YN; Zhao AH; Chen SD; Jia W
    J Proteome Res; 2014 May; 13(5):2649-58. PubMed ID: 24694177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.
    Costa AC; Joaquim HPG; Forlenza OV; Gattaz WF; Talib LL
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):483-488. PubMed ID: 31218445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.
    Han X; Rozen S; Boyle SH; Hellegers C; Cheng H; Burke JR; Welsh-Bohmer KA; Doraiswamy PM; Kaddurah-Daouk R
    PLoS One; 2011; 6(7):e21643. PubMed ID: 21779331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral benfotiamine reverts cognitive deficit and increase thiamine diphosphate levels in the brain of a rat model of neurodegeneration.
    Moraes RCM; Singulani MP; Gonçalves AC; Portari GV; Torrão ADS
    Exp Gerontol; 2020 Nov; 141():111097. PubMed ID: 32987117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous metabolomics and lipidomics analysis based on novel heart-cutting two-dimensional liquid chromatography-mass spectrometry.
    Wang S; Zhou L; Wang Z; Shi X; Xu G
    Anal Chim Acta; 2017 May; 966():34-40. PubMed ID: 28372724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Untargeted lipidomics reveals progression of early Alzheimer's disease in APP/PS1 transgenic mice.
    Zhang X; Liu W; Zan J; Wu C; Tan W
    Sci Rep; 2020 Sep; 10(1):14509. PubMed ID: 32884056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hearing Loss in Alzheimer's Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles.
    Llano DA; Issa LK; Devanarayan P; Devanarayan V; Alzheimer's Disease Neuroimaging Initiative Adni
    Cells; 2020 Nov; 9(12):. PubMed ID: 33260532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ
    Zhang M; Liu Y; Liu M; Liu B; Li N; Dong X; Hong Z; Chai Y
    Metabolomics; 2019 Jan; 15(2):13. PubMed ID: 30830431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.
    Anand S; Barnes JM; Young SA; Garcia DM; Tolley HD; Kauwe JSK; Graves SW
    J Alzheimers Dis; 2017; 59(1):277-290. PubMed ID: 28598845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic profiling of the effects of ginsenoside Re in an Alzheimer's disease mouse model.
    Li J; Liu Y; Li W; Wang Z; Guo P; Li L; Li N
    Behav Brain Res; 2018 Jan; 337():160-172. PubMed ID: 28927718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
    Sriwichaiin S; Chattipakorn N; Chattipakorn SC
    J Alzheimers Dis; 2021; 84(1):23-50. PubMed ID: 34511504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Metabolites in a Zebrafish Model of Alzheimer's Disease Supplemented with Mussel-Derived Plasmalogens by Ultraperformance Liquid Chromatography Q-Exactive Orbitrap Mass Spectrometry-Based Unbiased Metabolomics.
    Zhang M; Song G; Wang S; Ge L; Liu F; Zhang M; Xie H; Feng J; Shen Q
    J Agric Food Chem; 2021 Oct; 69(41):12187-12196. PubMed ID: 34623133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectives.
    Lista S; González-Domínguez R; López-Ortiz S; González-Domínguez Á; Menéndez H; Martín-Hernández J; Lucia A; Emanuele E; Centonze D; Imbimbo BP; Triaca V; Lionetto L; Simmaco M; Cuperlovic-Culf M; Mill J; Li L; Mapstone M; Santos-Lozano A; Nisticò R
    Ageing Res Rev; 2023 Aug; 89():101987. PubMed ID: 37343679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4
    Xu Q; Zhang Y; Zhang X; Liu L; Zhou B; Mo R; Li Y; Li H; Li F; Tao Y; Liu Y; Xue C
    Clin Nutr; 2020 Jul; 39(7):2092-2105. PubMed ID: 31694759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
    Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
    Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.